Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Revenue (2020 - 2025)

Historic Revenue for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $7.0 million.

  • Biofrontera's Revenue fell 2245.89% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 510.76%. This contributed to the annual value of $37.3 million for FY2024, which is 953.89% up from last year.
  • As of Q3 2025, Biofrontera's Revenue stood at $7.0 million, which was down 2245.89% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Revenue ranged from a high of $12.6 million in Q4 2024 and a low of $4.3 million during Q3 2022
  • Over the past 5 years, Biofrontera's median Revenue value was $8.6 million (recorded in 2025), while the average stood at $7.8 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 7692.02% in 2021, then surged by 10583.06% in 2023.
  • Biofrontera's Revenue (Quarter) stood at $9.2 million in 2021, then rose by 10.65% to $10.1 million in 2022, then rose by 4.46% to $10.6 million in 2023, then rose by 18.53% to $12.6 million in 2024, then crashed by 44.36% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $9.0 million for Q2 2025, and $8.6 million during Q1 2025.